Circulating gelatinases are not prognostic of treatment response and survival in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.

Ulger, Sukran; Kilic, Diclehan; Demircioglu, Fatih; Demirtas, Canan Y; Pasaoglu, Ozge T

Ulger, Sukran; Kilic, Diclehan; Demircioglu, Fatih; Demirtas, Canan Y; Pasaoglu, Ozge T.

Afiliação

Ulger S; Department of Radiation Oncology, Gazi University Hospital, Ankara, Turkey.
Kilic D; Department of Radiation Oncology, Gazi University Hospital, Ankara, Turkey.
Demircioglu F; Department of Radiation Oncology, Kartal Training and Research Hospital, Istanbul, Turkey.
Demirtas CY; Department of Biochemistry, Gazi University Hospital, Ankara, Turkey.
Pasaoglu OT; Department of Biochemistry, Gazi University Hospital, Ankara, Turkey.

J Cancer Res Ther ; 14(Supplement): S90-S96, 2018.

Article em En | MEDLINE | ID: mdl-29578156

Assuntos

Gelatinases/sangue; Metaloproteinase 2 da Matriz/sangue; Metaloproteinase 9 da Matriz/sangue; Neoplasias Retais/sangue; Neoplasias Retais/mortalidade; Biomarcadores; Quimiorradioterapia; Feminino; Humanos; Masculino; Metástase Neoplásica; Estadiamento de Neoplasias; Cuidados Pré-Operatórios; Prognóstico; Neoplasias Retais/patologia; Neoplasias Retais/terapia; Análise de Sobrevida; Resultado do Tratamento

Palavras-chave

Metalloproteinase-2; metalloproteinase-9; prognosis; rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Gelatinases / Metaloproteinase 2 da Matriz / Metaloproteinase 9 da Matriz Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google